nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranylcypromine—CYP2A6—Ifosfamide—testicular cancer	0.238	0.317	CbGbCtD
Tranylcypromine—CYP2C19—Ifosfamide—testicular cancer	0.0986	0.131	CbGbCtD
Tranylcypromine—CYP2C9—Ifosfamide—testicular cancer	0.082	0.109	CbGbCtD
Tranylcypromine—CYP2E1—Etoposide—testicular cancer	0.0752	0.0999	CbGbCtD
Tranylcypromine—CYP3A4—Ifosfamide—testicular cancer	0.0477	0.0633	CbGbCtD
Tranylcypromine—CYP1A2—Etoposide—testicular cancer	0.0435	0.0578	CbGbCtD
Tranylcypromine—CYP2C9—Cisplatin—testicular cancer	0.0399	0.053	CbGbCtD
Tranylcypromine—CYP2D6—Vinblastine—testicular cancer	0.0398	0.0528	CbGbCtD
Tranylcypromine—CYP3A4—Vinblastine—testicular cancer	0.0253	0.0336	CbGbCtD
Tranylcypromine—CYP2D6—Doxorubicin—testicular cancer	0.0244	0.0325	CbGbCtD
Tranylcypromine—CYP3A4—Etoposide—testicular cancer	0.0228	0.0303	CbGbCtD
Tranylcypromine—CYP3A4—Doxorubicin—testicular cancer	0.0155	0.0206	CbGbCtD
Tranylcypromine—Anorexia—Dactinomycin—testicular cancer	0.000749	0.00303	CcSEcCtD
Tranylcypromine—Diarrhoea—Chlorambucil—testicular cancer	0.000744	0.00302	CcSEcCtD
Tranylcypromine—Flushing—Etoposide—testicular cancer	0.000743	0.00301	CcSEcCtD
Tranylcypromine—Decreased appetite—Bleomycin—testicular cancer	0.000732	0.00297	CcSEcCtD
Tranylcypromine—Muscle spasms—Cisplatin—testicular cancer	0.000731	0.00296	CcSEcCtD
Tranylcypromine—Confusional state—Ifosfamide—testicular cancer	0.000726	0.00294	CcSEcCtD
Tranylcypromine—Pain—Bleomycin—testicular cancer	0.00072	0.00292	CcSEcCtD
Tranylcypromine—Oedema—Ifosfamide—testicular cancer	0.00072	0.00292	CcSEcCtD
Tranylcypromine—Chills—Etoposide—testicular cancer	0.000718	0.00291	CcSEcCtD
Tranylcypromine—Vision blurred—Cisplatin—testicular cancer	0.000717	0.0029	CcSEcCtD
Tranylcypromine—Asthenia—Vinblastine—testicular cancer	0.000715	0.0029	CcSEcCtD
Tranylcypromine—Tremor—Cisplatin—testicular cancer	0.000712	0.00289	CcSEcCtD
Tranylcypromine—Alopecia—Etoposide—testicular cancer	0.000707	0.00287	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Ifosfamide—testicular cancer	0.000705	0.00286	CcSEcCtD
Tranylcypromine—Anaemia—Cisplatin—testicular cancer	0.000703	0.00285	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Ifosfamide—testicular cancer	0.000696	0.00282	CcSEcCtD
Tranylcypromine—Feeling abnormal—Bleomycin—testicular cancer	0.000694	0.00281	CcSEcCtD
Tranylcypromine—Vomiting—Chlorambucil—testicular cancer	0.000692	0.0028	CcSEcCtD
Tranylcypromine—Anorexia—Ifosfamide—testicular cancer	0.000686	0.00278	CcSEcCtD
Tranylcypromine—Decreased appetite—Dactinomycin—testicular cancer	0.000683	0.00277	CcSEcCtD
Tranylcypromine—Diarrhoea—Vinblastine—testicular cancer	0.000682	0.00276	CcSEcCtD
Tranylcypromine—Leukopenia—Cisplatin—testicular cancer	0.000681	0.00276	CcSEcCtD
Tranylcypromine—Hypotension—Ifosfamide—testicular cancer	0.000673	0.00273	CcSEcCtD
Tranylcypromine—Pain—Dactinomycin—testicular cancer	0.000672	0.00272	CcSEcCtD
Tranylcypromine—Muscle spasms—Etoposide—testicular cancer	0.00067	0.00271	CcSEcCtD
Tranylcypromine—Urticaria—Bleomycin—testicular cancer	0.000669	0.00271	CcSEcCtD
Tranylcypromine—Body temperature increased—Bleomycin—testicular cancer	0.000666	0.0027	CcSEcCtD
Tranylcypromine—Dizziness—Vinblastine—testicular cancer	0.000659	0.00267	CcSEcCtD
Tranylcypromine—Ataxia—Methotrexate—testicular cancer	0.000651	0.00264	CcSEcCtD
Tranylcypromine—Feeling abnormal—Dactinomycin—testicular cancer	0.000647	0.00262	CcSEcCtD
Tranylcypromine—Nausea—Chlorambucil—testicular cancer	0.000646	0.00262	CcSEcCtD
Tranylcypromine—Paraesthesia—Ifosfamide—testicular cancer	0.000646	0.00262	CcSEcCtD
Tranylcypromine—Anxiety—Cisplatin—testicular cancer	0.000645	0.00261	CcSEcCtD
Tranylcypromine—Anaemia—Etoposide—testicular cancer	0.000644	0.00261	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000642	0.0026	CcSEcCtD
Tranylcypromine—Somnolence—Ifosfamide—testicular cancer	0.00064	0.00259	CcSEcCtD
Tranylcypromine—Vomiting—Vinblastine—testicular cancer	0.000634	0.00257	CcSEcCtD
Tranylcypromine—Decreased appetite—Ifosfamide—testicular cancer	0.000626	0.00254	CcSEcCtD
Tranylcypromine—Headache—Vinblastine—testicular cancer	0.000625	0.00253	CcSEcCtD
Tranylcypromine—Leukopenia—Etoposide—testicular cancer	0.000623	0.00253	CcSEcCtD
Tranylcypromine—Abdominal pain—Dactinomycin—testicular cancer	0.000621	0.00252	CcSEcCtD
Tranylcypromine—Body temperature increased—Dactinomycin—testicular cancer	0.000621	0.00252	CcSEcCtD
Tranylcypromine—Oedema—Cisplatin—testicular cancer	0.00062	0.00251	CcSEcCtD
Tranylcypromine—Constipation—Ifosfamide—testicular cancer	0.000615	0.00249	CcSEcCtD
Tranylcypromine—Pain—Ifosfamide—testicular cancer	0.000615	0.00249	CcSEcCtD
Tranylcypromine—Loss of consciousness—Etoposide—testicular cancer	0.000612	0.00248	CcSEcCtD
Tranylcypromine—Ataxia—Epirubicin—testicular cancer	0.00061	0.00247	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Cisplatin—testicular cancer	0.000608	0.00246	CcSEcCtD
Tranylcypromine—Tachycardia—Cisplatin—testicular cancer	0.000606	0.00245	CcSEcCtD
Tranylcypromine—Asthenia—Bleomycin—testicular cancer	0.000604	0.00245	CcSEcCtD
Tranylcypromine—Hypertension—Etoposide—testicular cancer	0.000601	0.00244	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Cisplatin—testicular cancer	0.0006	0.00243	CcSEcCtD
Tranylcypromine—Feeling abnormal—Ifosfamide—testicular cancer	0.000593	0.0024	CcSEcCtD
Tranylcypromine—Nausea—Vinblastine—testicular cancer	0.000592	0.0024	CcSEcCtD
Tranylcypromine—Anorexia—Cisplatin—testicular cancer	0.000591	0.0024	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000589	0.00239	CcSEcCtD
Tranylcypromine—Hypotension—Cisplatin—testicular cancer	0.00058	0.00235	CcSEcCtD
Tranylcypromine—Confusional state—Etoposide—testicular cancer	0.000573	0.00232	CcSEcCtD
Tranylcypromine—Urticaria—Ifosfamide—testicular cancer	0.000572	0.00232	CcSEcCtD
Tranylcypromine—Abdominal pain—Ifosfamide—testicular cancer	0.000569	0.00231	CcSEcCtD
Tranylcypromine—Body temperature increased—Ifosfamide—testicular cancer	0.000569	0.00231	CcSEcCtD
Tranylcypromine—Ataxia—Doxorubicin—testicular cancer	0.000564	0.00229	CcSEcCtD
Tranylcypromine—Asthenia—Dactinomycin—testicular cancer	0.000564	0.00228	CcSEcCtD
Tranylcypromine—Paraesthesia—Cisplatin—testicular cancer	0.000557	0.00226	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Etoposide—testicular cancer	0.000557	0.00226	CcSEcCtD
Tranylcypromine—Tachycardia—Etoposide—testicular cancer	0.000555	0.00225	CcSEcCtD
Tranylcypromine—Erectile dysfunction—Methotrexate—testicular cancer	0.000551	0.00223	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Etoposide—testicular cancer	0.00055	0.00223	CcSEcCtD
Tranylcypromine—Anorexia—Etoposide—testicular cancer	0.000542	0.0022	CcSEcCtD
Tranylcypromine—Decreased appetite—Cisplatin—testicular cancer	0.000539	0.00219	CcSEcCtD
Tranylcypromine—Diarrhoea—Dactinomycin—testicular cancer	0.000537	0.00218	CcSEcCtD
Tranylcypromine—Vomiting—Bleomycin—testicular cancer	0.000535	0.00217	CcSEcCtD
Tranylcypromine—Drowsiness—Methotrexate—testicular cancer	0.000534	0.00216	CcSEcCtD
Tranylcypromine—Hypotension—Etoposide—testicular cancer	0.000531	0.00215	CcSEcCtD
Tranylcypromine—Rash—Bleomycin—testicular cancer	0.000531	0.00215	CcSEcCtD
Tranylcypromine—Pain—Cisplatin—testicular cancer	0.000531	0.00215	CcSEcCtD
Tranylcypromine—Dermatitis—Bleomycin—testicular cancer	0.00053	0.00215	CcSEcCtD
Tranylcypromine—Pollakiuria—Epirubicin—testicular cancer	0.000518	0.0021	CcSEcCtD
Tranylcypromine—Asthenia—Ifosfamide—testicular cancer	0.000516	0.00209	CcSEcCtD
Tranylcypromine—Sweating—Methotrexate—testicular cancer	0.000512	0.00207	CcSEcCtD
Tranylcypromine—Feeling abnormal—Cisplatin—testicular cancer	0.000511	0.00207	CcSEcCtD
Tranylcypromine—Paraesthesia—Etoposide—testicular cancer	0.00051	0.00207	CcSEcCtD
Tranylcypromine—Somnolence—Etoposide—testicular cancer	0.000505	0.00205	CcSEcCtD
Tranylcypromine—Nausea—Bleomycin—testicular cancer	0.0005	0.00203	CcSEcCtD
Tranylcypromine—Drowsiness—Epirubicin—testicular cancer	0.0005	0.00202	CcSEcCtD
Tranylcypromine—Vomiting—Dactinomycin—testicular cancer	0.000499	0.00202	CcSEcCtD
Tranylcypromine—Agranulocytosis—Methotrexate—testicular cancer	0.000498	0.00202	CcSEcCtD
Tranylcypromine—Rash—Dactinomycin—testicular cancer	0.000495	0.00201	CcSEcCtD
Tranylcypromine—Decreased appetite—Etoposide—testicular cancer	0.000494	0.002	CcSEcCtD
Tranylcypromine—Diarrhoea—Ifosfamide—testicular cancer	0.000492	0.002	CcSEcCtD
Tranylcypromine—Body temperature increased—Cisplatin—testicular cancer	0.000491	0.00199	CcSEcCtD
Tranylcypromine—Pain—Etoposide—testicular cancer	0.000486	0.00197	CcSEcCtD
Tranylcypromine—Constipation—Etoposide—testicular cancer	0.000486	0.00197	CcSEcCtD
Tranylcypromine—Haemoglobin—Methotrexate—testicular cancer	0.000482	0.00195	CcSEcCtD
Tranylcypromine—Haemorrhage—Methotrexate—testicular cancer	0.000479	0.00194	CcSEcCtD
Tranylcypromine—Hepatitis—Methotrexate—testicular cancer	0.000479	0.00194	CcSEcCtD
Tranylcypromine—Sweating—Epirubicin—testicular cancer	0.000479	0.00194	CcSEcCtD
Tranylcypromine—Pollakiuria—Doxorubicin—testicular cancer	0.000479	0.00194	CcSEcCtD
Tranylcypromine—Dizziness—Ifosfamide—testicular cancer	0.000476	0.00193	CcSEcCtD
Tranylcypromine—Feeling abnormal—Etoposide—testicular cancer	0.000468	0.0019	CcSEcCtD
Tranylcypromine—Nausea—Dactinomycin—testicular cancer	0.000467	0.00189	CcSEcCtD
Tranylcypromine—Agranulocytosis—Epirubicin—testicular cancer	0.000466	0.00189	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Etoposide—testicular cancer	0.000465	0.00188	CcSEcCtD
Tranylcypromine—Drowsiness—Doxorubicin—testicular cancer	0.000462	0.00187	CcSEcCtD
Tranylcypromine—Vomiting—Ifosfamide—testicular cancer	0.000458	0.00185	CcSEcCtD
Tranylcypromine—Bradycardia—Epirubicin—testicular cancer	0.000457	0.00185	CcSEcCtD
Tranylcypromine—Rash—Ifosfamide—testicular cancer	0.000454	0.00184	CcSEcCtD
Tranylcypromine—Dermatitis—Ifosfamide—testicular cancer	0.000453	0.00184	CcSEcCtD
Tranylcypromine—Urticaria—Etoposide—testicular cancer	0.000452	0.00183	CcSEcCtD
Tranylcypromine—Haemoglobin—Epirubicin—testicular cancer	0.000451	0.00183	CcSEcCtD
Tranylcypromine—Abdominal pain—Etoposide—testicular cancer	0.000449	0.00182	CcSEcCtD
Tranylcypromine—Body temperature increased—Etoposide—testicular cancer	0.000449	0.00182	CcSEcCtD
Tranylcypromine—Haemorrhage—Epirubicin—testicular cancer	0.000449	0.00182	CcSEcCtD
Tranylcypromine—Hepatitis—Epirubicin—testicular cancer	0.000449	0.00182	CcSEcCtD
Tranylcypromine—Tinnitus—Methotrexate—testicular cancer	0.000447	0.00181	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Epirubicin—testicular cancer	0.000446	0.00181	CcSEcCtD
Tranylcypromine—Asthenia—Cisplatin—testicular cancer	0.000445	0.0018	CcSEcCtD
Tranylcypromine—Sweating—Doxorubicin—testicular cancer	0.000443	0.0018	CcSEcCtD
Tranylcypromine—Agranulocytosis—Doxorubicin—testicular cancer	0.000431	0.00175	CcSEcCtD
Tranylcypromine—Chills—Methotrexate—testicular cancer	0.00043	0.00174	CcSEcCtD
Tranylcypromine—Nausea—Ifosfamide—testicular cancer	0.000428	0.00173	CcSEcCtD
Tranylcypromine—Diarrhoea—Cisplatin—testicular cancer	0.000425	0.00172	CcSEcCtD
Tranylcypromine—Alopecia—Methotrexate—testicular cancer	0.000423	0.00172	CcSEcCtD
Tranylcypromine—Bradycardia—Doxorubicin—testicular cancer	0.000422	0.00171	CcSEcCtD
Tranylcypromine—Tinnitus—Epirubicin—testicular cancer	0.000418	0.00169	CcSEcCtD
Tranylcypromine—Haemoglobin—Doxorubicin—testicular cancer	0.000417	0.00169	CcSEcCtD
Tranylcypromine—Flushing—Epirubicin—testicular cancer	0.000416	0.00169	CcSEcCtD
Tranylcypromine—Haemorrhage—Doxorubicin—testicular cancer	0.000415	0.00168	CcSEcCtD
Tranylcypromine—Hepatitis—Doxorubicin—testicular cancer	0.000415	0.00168	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Doxorubicin—testicular cancer	0.000413	0.00167	CcSEcCtD
Tranylcypromine—Asthenia—Etoposide—testicular cancer	0.000408	0.00165	CcSEcCtD
Tranylcypromine—Chills—Epirubicin—testicular cancer	0.000402	0.00163	CcSEcCtD
Tranylcypromine—Alopecia—Epirubicin—testicular cancer	0.000396	0.00161	CcSEcCtD
Tranylcypromine—Vomiting—Cisplatin—testicular cancer	0.000395	0.0016	CcSEcCtD
Tranylcypromine—Vision blurred—Methotrexate—testicular cancer	0.000393	0.00159	CcSEcCtD
Tranylcypromine—Rash—Cisplatin—testicular cancer	0.000391	0.00159	CcSEcCtD
Tranylcypromine—Dermatitis—Cisplatin—testicular cancer	0.000391	0.00158	CcSEcCtD
Tranylcypromine—Diarrhoea—Etoposide—testicular cancer	0.000389	0.00158	CcSEcCtD
Tranylcypromine—Tinnitus—Doxorubicin—testicular cancer	0.000387	0.00157	CcSEcCtD
Tranylcypromine—Anaemia—Methotrexate—testicular cancer	0.000386	0.00156	CcSEcCtD
Tranylcypromine—Flushing—Doxorubicin—testicular cancer	0.000385	0.00156	CcSEcCtD
Tranylcypromine—Dizziness—Etoposide—testicular cancer	0.000376	0.00152	CcSEcCtD
Tranylcypromine—Muscle spasms—Epirubicin—testicular cancer	0.000375	0.00152	CcSEcCtD
Tranylcypromine—Leukopenia—Methotrexate—testicular cancer	0.000373	0.00151	CcSEcCtD
Tranylcypromine—Chills—Doxorubicin—testicular cancer	0.000372	0.00151	CcSEcCtD
Tranylcypromine—Nausea—Cisplatin—testicular cancer	0.000369	0.00149	CcSEcCtD
Tranylcypromine—Vision blurred—Epirubicin—testicular cancer	0.000368	0.00149	CcSEcCtD
Tranylcypromine—Alopecia—Doxorubicin—testicular cancer	0.000367	0.00149	CcSEcCtD
Tranylcypromine—Vomiting—Etoposide—testicular cancer	0.000361	0.00146	CcSEcCtD
Tranylcypromine—Anaemia—Epirubicin—testicular cancer	0.000361	0.00146	CcSEcCtD
Tranylcypromine—Agitation—Epirubicin—testicular cancer	0.000359	0.00145	CcSEcCtD
Tranylcypromine—Rash—Etoposide—testicular cancer	0.000358	0.00145	CcSEcCtD
Tranylcypromine—Dermatitis—Etoposide—testicular cancer	0.000358	0.00145	CcSEcCtD
Tranylcypromine—Headache—Etoposide—testicular cancer	0.000356	0.00144	CcSEcCtD
Tranylcypromine—Syncope—Epirubicin—testicular cancer	0.00035	0.00142	CcSEcCtD
Tranylcypromine—Leukopenia—Epirubicin—testicular cancer	0.000349	0.00142	CcSEcCtD
Tranylcypromine—Muscle spasms—Doxorubicin—testicular cancer	0.000347	0.00141	CcSEcCtD
Tranylcypromine—Palpitations—Epirubicin—testicular cancer	0.000345	0.0014	CcSEcCtD
Tranylcypromine—Confusional state—Methotrexate—testicular cancer	0.000343	0.00139	CcSEcCtD
Tranylcypromine—Loss of consciousness—Epirubicin—testicular cancer	0.000343	0.00139	CcSEcCtD
Tranylcypromine—Vision blurred—Doxorubicin—testicular cancer	0.00034	0.00138	CcSEcCtD
Tranylcypromine—Nausea—Etoposide—testicular cancer	0.000338	0.00137	CcSEcCtD
Tranylcypromine—Hypertension—Epirubicin—testicular cancer	0.000337	0.00137	CcSEcCtD
Tranylcypromine—Anaemia—Doxorubicin—testicular cancer	0.000334	0.00135	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Methotrexate—testicular cancer	0.000333	0.00135	CcSEcCtD
Tranylcypromine—Agitation—Doxorubicin—testicular cancer	0.000332	0.00135	CcSEcCtD
Tranylcypromine—Anxiety—Epirubicin—testicular cancer	0.000331	0.00134	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Methotrexate—testicular cancer	0.000329	0.00133	CcSEcCtD
Tranylcypromine—Dry mouth—Epirubicin—testicular cancer	0.000325	0.00132	CcSEcCtD
Tranylcypromine—Anorexia—Methotrexate—testicular cancer	0.000325	0.00132	CcSEcCtD
Tranylcypromine—Syncope—Doxorubicin—testicular cancer	0.000324	0.00131	CcSEcCtD
Tranylcypromine—Leukopenia—Doxorubicin—testicular cancer	0.000323	0.00131	CcSEcCtD
Tranylcypromine—Confusional state—Epirubicin—testicular cancer	0.000321	0.0013	CcSEcCtD
Tranylcypromine—Palpitations—Doxorubicin—testicular cancer	0.000319	0.00129	CcSEcCtD
Tranylcypromine—Oedema—Epirubicin—testicular cancer	0.000319	0.00129	CcSEcCtD
Tranylcypromine—Hypotension—Methotrexate—testicular cancer	0.000318	0.00129	CcSEcCtD
Tranylcypromine—Loss of consciousness—Doxorubicin—testicular cancer	0.000318	0.00129	CcSEcCtD
Tranylcypromine—Shock—Epirubicin—testicular cancer	0.000313	0.00127	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Epirubicin—testicular cancer	0.000312	0.00126	CcSEcCtD
Tranylcypromine—Hypertension—Doxorubicin—testicular cancer	0.000312	0.00126	CcSEcCtD
Tranylcypromine—Tachycardia—Epirubicin—testicular cancer	0.000311	0.00126	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Epirubicin—testicular cancer	0.000308	0.00125	CcSEcCtD
Tranylcypromine—Insomnia—Methotrexate—testicular cancer	0.000308	0.00125	CcSEcCtD
Tranylcypromine—Anxiety—Doxorubicin—testicular cancer	0.000306	0.00124	CcSEcCtD
Tranylcypromine—Paraesthesia—Methotrexate—testicular cancer	0.000306	0.00124	CcSEcCtD
Tranylcypromine—Anorexia—Epirubicin—testicular cancer	0.000304	0.00123	CcSEcCtD
Tranylcypromine—Somnolence—Methotrexate—testicular cancer	0.000303	0.00123	CcSEcCtD
Tranylcypromine—Dry mouth—Doxorubicin—testicular cancer	0.000301	0.00122	CcSEcCtD
Tranylcypromine—Hypotension—Epirubicin—testicular cancer	0.000298	0.00121	CcSEcCtD
Tranylcypromine—Confusional state—Doxorubicin—testicular cancer	0.000297	0.0012	CcSEcCtD
Tranylcypromine—Decreased appetite—Methotrexate—testicular cancer	0.000296	0.0012	CcSEcCtD
Tranylcypromine—Oedema—Doxorubicin—testicular cancer	0.000295	0.00119	CcSEcCtD
Tranylcypromine—Pain—Methotrexate—testicular cancer	0.000291	0.00118	CcSEcCtD
Tranylcypromine—Shock—Doxorubicin—testicular cancer	0.00029	0.00118	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000289	0.00117	CcSEcCtD
Tranylcypromine—Insomnia—Epirubicin—testicular cancer	0.000288	0.00117	CcSEcCtD
Tranylcypromine—Tachycardia—Doxorubicin—testicular cancer	0.000288	0.00117	CcSEcCtD
Tranylcypromine—Paraesthesia—Epirubicin—testicular cancer	0.000286	0.00116	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000285	0.00116	CcSEcCtD
Tranylcypromine—Somnolence—Epirubicin—testicular cancer	0.000283	0.00115	CcSEcCtD
Tranylcypromine—Anorexia—Doxorubicin—testicular cancer	0.000281	0.00114	CcSEcCtD
Tranylcypromine—Feeling abnormal—Methotrexate—testicular cancer	0.000281	0.00114	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000278	0.00113	CcSEcCtD
Tranylcypromine—Decreased appetite—Epirubicin—testicular cancer	0.000277	0.00112	CcSEcCtD
Tranylcypromine—Hypotension—Doxorubicin—testicular cancer	0.000275	0.00112	CcSEcCtD
Tranylcypromine—Constipation—Epirubicin—testicular cancer	0.000272	0.0011	CcSEcCtD
Tranylcypromine—Pain—Epirubicin—testicular cancer	0.000272	0.0011	CcSEcCtD
Tranylcypromine—Urticaria—Methotrexate—testicular cancer	0.00027	0.0011	CcSEcCtD
Tranylcypromine—Abdominal pain—Methotrexate—testicular cancer	0.000269	0.00109	CcSEcCtD
Tranylcypromine—Body temperature increased—Methotrexate—testicular cancer	0.000269	0.00109	CcSEcCtD
Tranylcypromine—Insomnia—Doxorubicin—testicular cancer	0.000267	0.00108	CcSEcCtD
Tranylcypromine—Paraesthesia—Doxorubicin—testicular cancer	0.000265	0.00107	CcSEcCtD
Tranylcypromine—Feeling abnormal—Epirubicin—testicular cancer	0.000263	0.00106	CcSEcCtD
Tranylcypromine—Somnolence—Doxorubicin—testicular cancer	0.000262	0.00106	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000261	0.00106	CcSEcCtD
Tranylcypromine—Decreased appetite—Doxorubicin—testicular cancer	0.000256	0.00104	CcSEcCtD
Tranylcypromine—Urticaria—Epirubicin—testicular cancer	0.000253	0.00103	CcSEcCtD
Tranylcypromine—Constipation—Doxorubicin—testicular cancer	0.000252	0.00102	CcSEcCtD
Tranylcypromine—Pain—Doxorubicin—testicular cancer	0.000252	0.00102	CcSEcCtD
Tranylcypromine—Abdominal pain—Epirubicin—testicular cancer	0.000252	0.00102	CcSEcCtD
Tranylcypromine—Body temperature increased—Epirubicin—testicular cancer	0.000252	0.00102	CcSEcCtD
Tranylcypromine—Asthenia—Methotrexate—testicular cancer	0.000244	0.00099	CcSEcCtD
Tranylcypromine—Feeling abnormal—Doxorubicin—testicular cancer	0.000243	0.000985	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000241	0.000977	CcSEcCtD
Tranylcypromine—Urticaria—Doxorubicin—testicular cancer	0.000234	0.000949	CcSEcCtD
Tranylcypromine—Abdominal pain—Doxorubicin—testicular cancer	0.000233	0.000945	CcSEcCtD
Tranylcypromine—Body temperature increased—Doxorubicin—testicular cancer	0.000233	0.000945	CcSEcCtD
Tranylcypromine—Diarrhoea—Methotrexate—testicular cancer	0.000233	0.000944	CcSEcCtD
Tranylcypromine—Asthenia—Epirubicin—testicular cancer	0.000229	0.000926	CcSEcCtD
Tranylcypromine—Dizziness—Methotrexate—testicular cancer	0.000225	0.000912	CcSEcCtD
Tranylcypromine—Diarrhoea—Epirubicin—testicular cancer	0.000218	0.000884	CcSEcCtD
Tranylcypromine—Vomiting—Methotrexate—testicular cancer	0.000216	0.000877	CcSEcCtD
Tranylcypromine—Rash—Methotrexate—testicular cancer	0.000215	0.00087	CcSEcCtD
Tranylcypromine—Dermatitis—Methotrexate—testicular cancer	0.000214	0.000869	CcSEcCtD
Tranylcypromine—Headache—Methotrexate—testicular cancer	0.000213	0.000864	CcSEcCtD
Tranylcypromine—Asthenia—Doxorubicin—testicular cancer	0.000212	0.000857	CcSEcCtD
Tranylcypromine—Dizziness—Epirubicin—testicular cancer	0.000211	0.000854	CcSEcCtD
Tranylcypromine—Vomiting—Epirubicin—testicular cancer	0.000203	0.000821	CcSEcCtD
Tranylcypromine—Nausea—Methotrexate—testicular cancer	0.000202	0.00082	CcSEcCtD
Tranylcypromine—Diarrhoea—Doxorubicin—testicular cancer	0.000202	0.000818	CcSEcCtD
Tranylcypromine—Rash—Epirubicin—testicular cancer	0.000201	0.000814	CcSEcCtD
Tranylcypromine—Dermatitis—Epirubicin—testicular cancer	0.000201	0.000813	CcSEcCtD
Tranylcypromine—Headache—Epirubicin—testicular cancer	0.0002	0.000809	CcSEcCtD
Tranylcypromine—Dizziness—Doxorubicin—testicular cancer	0.000195	0.00079	CcSEcCtD
Tranylcypromine—Nausea—Epirubicin—testicular cancer	0.000189	0.000767	CcSEcCtD
Tranylcypromine—Vomiting—Doxorubicin—testicular cancer	0.000187	0.00076	CcSEcCtD
Tranylcypromine—Rash—Doxorubicin—testicular cancer	0.000186	0.000753	CcSEcCtD
Tranylcypromine—Dermatitis—Doxorubicin—testicular cancer	0.000186	0.000753	CcSEcCtD
Tranylcypromine—Headache—Doxorubicin—testicular cancer	0.000185	0.000749	CcSEcCtD
Tranylcypromine—Nausea—Doxorubicin—testicular cancer	0.000175	0.00071	CcSEcCtD
